Nanobodies: new avenue to treat kidney disease
Related Research units
Abstract
Current therapeutic options for renal diseases are limited, and the search for disease-specific treatments is ongoing. Nanobodies, single-domain antibodies with many advantages over conventional antibodies, provide flexible, easy-to-format biologicals with many possible applications. Here, we discuss the potential use of nanobodies for renal diseases.
Bibliographical data
Original language | English |
---|---|
ISSN | 0302-766X |
DOIs | |
Publication status | Published - 08.2021 |
PubMed | 34131806 |
---|